109 related articles for article (PubMed ID: 8541229)
1. Estrogen receptor blockade by the pure antiestrogen, ZM 182780, induces death of pituitary tumour cells.
Newton CJ
J Steroid Biochem Mol Biol; 1995 Dec; 55(3-4):327-36. PubMed ID: 8541229
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth.
Chun TY; Gregg D; Sarkar DK; Gorski J
Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2325-30. PubMed ID: 9482884
[TBL] [Abstract][Full Text] [Related]
3. The unliganded estrogen receptor (ER) transduces growth factor signals.
Newton CJ; Buric R; Trapp T; Brockmeier S; Pagotto U; Stalla GK
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):481-6. PubMed ID: 8180109
[TBL] [Abstract][Full Text] [Related]
4. Response of estrogen receptor containing tumour cells to pure antiestrogens and the calmodulin inhibitor, calmidzolium chloride.
Newton CJ; Eycott K; Green V; Atkin SL
J Steroid Biochem Mol Biol; 2000 May; 73(1-2):29-38. PubMed ID: 10822022
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the estrogen receptor in the growth response of pituitary tumor cells to interleukin-2.
Newton CJ; Arzt E; Stalla GK
Biochem Biophys Res Commun; 1994 Dec; 205(3):1930-7. PubMed ID: 7811284
[TBL] [Abstract][Full Text] [Related]
6. Functional inactivation of the oestrogen receptor by the antioestrogen, ZM 182780, sensitises tumour cells to reactive oxygen species.
Newton CJ; Drummond N; Burgoyne CH; Speirs V; Stalla GK; Atkin SL
J Endocrinol; 1999 May; 161(2):199-210. PubMed ID: 10320817
[TBL] [Abstract][Full Text] [Related]
7. Phytoestrogens act as estrogen agonists in an estrogen-responsive pituitary cell line.
Stahl S; Chun TY; Gray WG
Toxicol Appl Pharmacol; 1998 Sep; 152(1):41-8. PubMed ID: 9772198
[TBL] [Abstract][Full Text] [Related]
8. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
Montano MM; Ekena K; Krueger KD; Keller AL; Katzenellenbogen BS
Mol Endocrinol; 1996 Mar; 10(3):230-42. PubMed ID: 8833652
[TBL] [Abstract][Full Text] [Related]
9. High concentrations of bisphenol A induce cell growth and prolactin secretion in an estrogen-responsive pituitary tumor cell line.
Chun TY; Gorski J
Toxicol Appl Pharmacol; 2000 Feb; 162(3):161-5. PubMed ID: 10652244
[TBL] [Abstract][Full Text] [Related]
10. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
Newton CJ; Trapp T; Pagotto U; Renner U; Buric R; Stalla GK
J Mol Endocrinol; 1994 Jun; 12(3):303-12. PubMed ID: 7916969
[TBL] [Abstract][Full Text] [Related]
11. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
12. Differences in morphology and cytoskeleton of MCF-7 and MX-1 cells after therapy with OH-tamoxifen and the pure estrogen antagonist ZM 182780. An immunofluorescence and scanning electron microscopic study.
Ehlers EM; Schubert C
Ann Anat; 1999 May; 181(3):231-6. PubMed ID: 10363104
[TBL] [Abstract][Full Text] [Related]
13. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
14. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
Zhou-Li F; Albaladejo V; Joly-Pharaboz MO; Nicolas B; Andre J
Endocrinology; 1992 Mar; 130(3):1145-52. PubMed ID: 1537281
[TBL] [Abstract][Full Text] [Related]
15. Effect of growth factors on estrogen receptor mediated gene expression.
Hafner F; Holler E; von Angerer E
J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrone, estradiol, and estriol on hormone-responsive human breast cancer in long-term tissue culture.
Lippman M; Monaco ME; Bolan G
Cancer Res; 1977 Jun; 37(6):1901-7. PubMed ID: 870192
[TBL] [Abstract][Full Text] [Related]
17. The interaction of raloxifene and the active metabolite of the antiestrogen EM-800 (SC 5705) with the human estrogen receptor.
Schafer JI; Liu H; Tonetti DA; Jordan VC
Cancer Res; 1999 Sep; 59(17):4308-13. PubMed ID: 10485477
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a cell line that stably expresses an estrogen-responsive luciferase reporter for the detection of estrogen receptor agonist and antagonists.
Wilson VS; Bobseine K; Gray LE
Toxicol Sci; 2004 Sep; 81(1):69-77. PubMed ID: 15166400
[TBL] [Abstract][Full Text] [Related]
19. Estrogen mitogenic action. I. Demonstration of estrogen-dependent MTW9/PL2 carcinogen-induced rat mammary tumor cell growth in serum-supplemented culture and technical implications.
Moreno-Cuevas JE; Sirbasku DA
In Vitro Cell Dev Biol Anim; 2000; 36(7):410-27. PubMed ID: 11039493
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone blocks antioestrogen- and oxidant-induced death of pituitary tumour cells.
Newton CJ; Bilko D; Pappa S; Atkin SL
J Endocrinol; 2001 May; 169(2):249-61. PubMed ID: 11312142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
